U.K. Home Healthcare Market Size, Share & COVID-19 Impact Analysis, By Product (Continence Care {Briefs & Diapers, Catheters & Bags, Underpads & Liners, and Others}, Wound Care {Traditional Wound Dressings, Advanced Wound Dressings, Negative Pressure Wound Therapy (NPWT), and Others}, Ostomy Care {Ostomy Care Bags and Accessories}, Clinical Nutrition {Parenteral Nutrition and Enteral Nutrition}, Respiratory Care, Housekeeping Supplies & Equipment, and Others), and Country Forecast, 2023-2030

The U.K. home healthcare market size was valued at USD 1.50 billion in 2022. The market is projected to grow from USD 1.61 billion in 2023 to USD 2.60 billion by 2030, exhibiting a CAGR of 7.1% during the forecast period.

Home healthcare is a wide-ranging healthcare service that can be given at home for an injury or illness. The services are less expensive, convenient, and efficient than hospital services. The increasing economic burden on NHS healthcare spending has increased the need for new healthcare systems, such as home healthcare. As a result, home care expenditures, as a proportion of GDP, have increased since the last decade. Adopting this concept will reduce the overall burden of healthcare costs by reducing the number of hospital stays.

Additionally, the growing geriatric population with the increasing prevalence of chronic diseases, such as incontinence, ostomy, diabetic foot ulcer, and others, that can be taken care of at home will drive the market growth in the U.K. The shift in the delivery of many healthcare services from traditional institutional settings to home care and the need for cost-effective care solutions is expected to drive market growth during the forecast period.

COVID-19 Impact

Decreased Patient Visits for Chronic Care During COVID-19 Pandemic Hampered Market Growth

The COVID-19 Pandemic negatively impacted the U.K. home healthcare market. Overall. The drop was attributed to the strict lockdown procedures during the pandemic, and interruptions for chronic disorders care hindered market growth. This situation contributed to the drop in patient visits and elective surgeries during the pandemic.

Moreover, the key players experienced a considerable decrease in revenue owing to the lack of demand for continence, ostomy, and wound care during the COVID-19 pandemic.

• For instance, key players, including Smith+Nephew, registered a significant decrease of 21.3% in the U.K. advanced wound management annual sales in 2020. In 2021, the company’s segment witnessed an increase of 13.9% in its U.K. revenues.

Furthermore, the rising patient visits and elective surgeries for chronic care post-pandemic are estimated to raise home healthcare adoption, driving market growth during the forecast period.

LATEST TRENDS

Incorporation of Remote Patient Monitoring to Cater Growing Patient Needs to Drive Market Growth

In recent years, the U.K. market witnessed a trend of remote patient monitoring. Remote patient monitoring for home healthcare provides a better ability to manage chronic conditions, reduces the risk of disease transmission, lowers cost, and increases efficiencies. Hence, it is estimated that more patients will adopt such a trend.

• For instance, in January 2023, Omron Healthcare launched a remote patient monitoring service called Viso to transform chronic care management in the U.K. Viso is an NHS-approved app that allows physicians and patients to manage common long-term health conditions like high blood pressure, diabetes, and heart diseases.

Currently, several companies are engaging in remote patient monitoring and launching new products for this market. This factor drives market growth during the forecast period.

Request a Free sample to learn more about this report.

DRIVING FACTORS

Increasing Geriatric Population and High Prevalence of Chronic Illness to Boost Market Growth

The growing aging population, prone to chronic diseases, such as diabetes, hypertension, Alzheimer's, mental illness, incontinence, and others, is expected to boost the demand for an easy-to-access and cost-effective healthcare system at home. According to an article published by the Office of National Statistics in 2022, over 11.0 million or 18.6% of the total population were aged 65 years or older in the U.K. This offers an ample opportunity for the growth of the products by 2030 since the adoption of these products is higher by the elderly population.

Moreover, technological advancements in healthcare devices have helped increase care for the dependent elderly population and patients treating chronic diseases at home healthcare facilities. Various advantages are provided by healthcare technologies, such as empowering patients by making them less dependent on healthcare professionals, driving market growth. Additionally, the improved quality of care, close monitoring of healthcare parameters, ease of access, and reduced cost of care compared to institutional care will fuel the market growth in the U.K. during the forecast period.

Crisis in social care, new value-based payment and care models, and the growing adoption of advanced home care technologies leverage lucrative opportunities to invest in this industry in the U.K.

Rising Inclination Toward Home Healthcare Services to Augment Market Growth

The growing cases of chronic diseases has created a substantial burden in the U.K. Such scenarios are increasing average hospital admissions. However, in treating long-term disorders, the cost burden also increases. These factors promote patients’ preference for cost-effective options, including home healthcare services. According to an article published by the National Institute for Health and Care Research (NIHR) in 2022, home care services are cheaper than hospital care. This service led to no more deaths after six months or one year among the people admitted to hospitals in the U.K.

Also, homecare settings reduce the risk of infections in many ways. Such benefits and cost-effectiveness drive the market size in the U.K.

RESTRAINING FACTORS

Potential Gaps in Home Healthcare Service Providers to Hinder Market Growth

Even if the demand for home healthcare products and services is continuously growing, some factors hamper market growth in the U.K. These factors include user experience, psychological abuse or neglectful care practice, harm related to the care home environment, and the processes for integrated learning restrain the U.K. home healthcare market growth.

• For instance, according to an article published by BMJ Journal in 2020, healthcare service research was conducted in the care home sector in England. It was found that there was a range of available safety measures used for quality monitoring and improvement in older adult care homes. Still, some potential gaps were there in homecare settings.

Additionally, care home residents are at greater risk of harm, abuse, or neglect. Hence, factors such as availability of trained caregivers during emergencies, and home safety concerns is limiting the adoption of homecare products and services. Therefore, such factors are hampering the U.K. home healthcare market expansion during the forecast period.

SEGMENTATION

By Product Analysis

Wide Range of Medical Devices and their Vast Application Boosts Housekeeping Supplies & Equipment Segment Growth

Based on product, the market is segmented into continence care, wound care, ostomy care, clinical nutrition, respiratory care, housekeeping supplies & equipment, and others.

The housekeeping supplies & equipment segment captured the largest U.K. home healthcare market share in 2022. This is attributable to redesigning the medical devices already used for institutional care by manufacturers to fulfill the need for home healthcare facilities. The high cost, growing adoption of advanced technologies among the U.K. population, and growing elderly population are poised to propel market growth during the forecast period, leveraging lucrative opportunities for the manufacturers.

The continence care segment is further classified as briefs & diapers, catheters & bags, under pads & liners, and others. The continence care segment accounted for the second largest share of the market in the U.K. owing to a large population suffering from urinary or fecal incontinence issues.

• For instance, as per the estimates published by NHS form in 2023, about 3.0-6.0 million people in the U.K. may have some urinary incontinence.

The wound care segment is further classified as traditional wound dressings, advanced wound dressings, Negative Pressure Wound Therapy (NPWT), and others. The rising incidence of diabetes is increasing the demand for wound care products, thus propelling the segment’s expansion. The ostomy care is divided into ostomy care bags and accessories.

Clinical nutrition is sub-segmented into parenteral nutrition and enteral nutrition. The growing prevalence of digestive disorders and malnutrition contributes to segmental growth.

The respiratory care and others segment held a substantial share during the forecast period. Some commonly used home care services in respiratory therapy included oxygen therapy and airway management/tracheostomy care. In U.K. various healthcare centers do assign respiratory therapists who can deliver quality respiratory care services to individuals. The strong demand for such facilities is anticipated to promote the segmental expansion.

The others segment includes various therapy services and short term services. The rising prevalence of disease conditions in which these therapies are required and growing adoption of medical facilities is supporting the segmental growth.

To know how our report can help streamline your business, Speak to Analyst

KEY INDUSTRY PLAYERS

Smith+Nephew and Coloplast Corp Dominated the Market in 2022 Owing to Strong Strategic Investments and Product Portfolio 

The competitive landscape of the U.K. market is consolidated type, as key companies, such as Smith+Nephew, Coloplast Corp, Mölnlycke Health Care AB., Convatec Inc., and Hollister Incorporated. These players accounted for a significant proportion of the market share in 2022. These companies strongly focus on new product launches, investments, and mergers & acquisitions, which enabled them to gain a prominent position in 2022.

• For instance, in June 2022, Smith+Nephew announced  a new R&D and manufacturing facility for its Advanced Wound Management franchise on the outskirts of Hull, U.K. The company will invest over USD 100.0 million to create a world-class R&D, manufacturing, and flexible office environment. These initiatives have significantly contributed towards the company's strong market share.

The other key players in the market include B. Braun SE, 3M, Fresenius Medical Care AG & Co. KGaA, and Medline Industries, Inc. The growing emphasis on partnerships and acquisitions with other major players to widen the portfolio are some factors that contribute to these companies’ market expansion.

LIST OF KEY COMPANIES PROFILED:

• Coloplast Corp (Denmark)


• B. Braun SE (Germany)


• Holister Incorporated (U.S.)


• Convatec Group PLC (U.K.)


• Smith+Nephew (U.K.)


• Molnlycke Helth Care AB (Sweden)


• 3M (U.S.)


• Fresenius Medical Care AG & Co. KGaA (Germany)


• Medline Industries, Inc. (U.S.)

KEY INDUSTRY DEVELOPMENTS:

• December 2022: Nurseplus, a U.K. based provider of nursing and care services had launched ‘Care at home’ service in Aylesbury, U.K. for long-term care residents.


• December 2022: Healthium announced the sale of Clinisupplies, a U.K.-based subsidiary. The company Clinisupplies has a strong portfolio of products in continence care and partners with the NHS to supply quality and cost-effective continence care products.


• June 2022: Fresenius Kabi U.K. announced the launch of a new website supporting professionals engaged in the parenteral nutrition market. The website contains information regarding adults needing parenteral nutrition in different clinical settings.


• June 2021: Ontex Smart, a Belgium-based international personal hygiene group had launched diaper service under the brand Orizon in n Belgium, France, Germany, Italy and the U.K. This will enhance the continence care efficiency and dignity in the Europe.


• November 2020: Trio Healthcare (Trio), UK-based ostomy specialist secured a multi-million-pound financing from SWK Holdings Corporation. This finacing has been utilized for ostomy care product launch.

REPORT COVERAGE

The market report provides qualitative and quantitative insights and a detailed analysis of the market trends in the U.K. based on product types. The report also elaborates on the U.K. home healthcare market analysis, potentials, market dynamics, and competitive landscape. The report provides key insights: the reimbursement scenario for the market in the U.K., the aging population, the industry structure, long-term care GDP expenditure, U.K., government initiatives in home healthcare in the U.K., and key industry developments. The report also provides a competitive analysis and COVID-19's impact on the market.

Report Scope & Segmentation